Nippon Life Global Investors Americas’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Nippon Life Global Investors Americas's LLY Position: Q2 2026 in Review
Nippon Life Global Investors Americas reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $11.7M and leaving 64,390 shares worth $77.2M. The position accounts for 3.07% of the portfolio, ranked #7.
Nippon Life Global Investors Americas first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $85M in Q2 2024. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Nippon Life Global Investors Americas held 64,390 shares of Eli Lilly worth $77.2M as of Q2 2026.
- Nippon Life Global Investors Americas sold 11,420 Eli Lilly shares in Q2 2026, an estimated $11.7M.
- Eli Lilly made up 3.07% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #7 holding.
- Nippon Life Global Investors Americas first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- Nippon Life Global Investors Americas's Eli Lilly position peaked at $85M in Q2 2024.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.